Readers of MassTortDefense know how FDA regulatory treatment of advertising and promotion can impact product liability litigation involving drugs and
Continue Reading Device Group Comments on FDA Draft Guidance on Risk Information
Mass Tort Defense
Defense of Mass Tort Claims, Class Actions, and Significant Product-Based Litigation